• CANCER EARLY DETECTION

    Improving the Quality of Life and Reducing of Total Medical Costs
  • CANCER EARLY DETECTION

    Maintain healthy life quality of aging society
  • CANCER EARLY DETECTION

    EarlyTect® powered by DNA methylation biomarker

EarlyTect® Products for Cancer Early Detection

  • EarlyTect® Colon Cancer

    for early detection of colorectal cancer
  • EarlyTect® Lung Cancer

    for early detection of high risk lung cancer patient with pulmonary nodules
  • EarlyTect® Bladder Cancer

    for triage of hematuria patients to need cystoscopy
  • AccuraTect™

    for cancer companion diagnotics

EarlyTect® Products for Cancer Early Detection

  • EarlyTect® Colon Cancer

    for early detection of colorectal cancer
  • EarlyTect® Lung Cancer

    for early detection of high risk lung cancer patient with pulmonary nodules
  • EarlyTect® Bladder Cancer

    for triage of hematuria patients to need cystoscopy
  • AccuraTect™

    for cancer companion diagnotics

Pipeline

Pipeline
Pipeline

ABOUT US

Company

PANDEMIC

2019 CORONA VIRUS


Molecular Diagnostics, AccuraDTectTM SARS-CoV-2 RT-qPCR Kit, FDA EUA submitted

 

AccuraDTectTM SARS-CoV-2 RT-qPCR Kit contains the assays and controls for a real-time reve rse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative detection of RNAs (Leader sequence and N gene which are RNA targets present most abundantly in infected cells) from SARS-CoV-2 in upper respiratory specimens (nasopharyngeal or oropharyngeal swabs) from individuals suspected of COVID-19 by their healthcare provider.

 

Click ↓ The instructions for use, including a summary of assay performance 

AccuraDTect™ SARS-CoV-2 RT-qPCR Kit

SARS-CoV-2 Viewing Program Download SARS-CoV-2 Viewing Manual Download